Additionally, treatment of lymphoma cells from Lck-Dlx5;Lck-MyrAkt2 mice with β-catenin/Tcf inhibitors demonstrated that β-catenin signaling plays a critical role in promoting cell survival. This evidence concerns the gene DLX5 and lymphoma.